Consensus Ventas, Inc.

Stocks

VTR

US92276F1003

Specialized REITs

Real-time Estimate Cboe BZX 03:30:17 09/09/26 am AEST			5-day change	1st Jan Change
91.21 ^USD	+1.04%		-1.15%	+17.61%

02/09	Scotiabank Adjusts Price Target on Ventas to $95 From $93, Maintains Sector Perform Rating	MT
02/09	JPMorgan Adjusts Price Target on Ventas to $104 From $94, Maintains Overweight Rating	MT

Evolution of the Average Target: Ventas, Inc.

Evolution of the Target Price: Ventas, Inc.

Changes in Analyst Recommendations: Ventas, Inc.

0f8049997bd86aa0f873cb02f.2CPOgHzU6Xbt0Vblp4zC_CxlyC7fpRHc62R06xyia0c.vEGb9CyHvT-lnjyh4P_ztEA6m3un6SOrhyIMkU7lHyK5E4bBCL6KGIDiEw~37fc72f163b345dd2058c240b8acb2f2

Analysts' recommendations: Ventas, Inc.

02/09	Scotiabank Adjusts Price Target on Ventas to $95 From $93, Maintains Sector Perform Rating	MT
02/09	JPMorgan Adjusts Price Target on Ventas to $104 From $94, Maintains Overweight Rating	MT
01/09	Wells Fargo Adjusts Price Target on Ventas to $104 From $96, Maintains Overweight Rating	MT
31/08	Barclays Adjusts Price Target on Ventas to $102 From $99, Keeps Equalweight Rating	MT
15/08	Ventas Earnings Growth Supported by Strong Senior Housing Trends, RBC Says	MT
14/08	RBC Adjusts Price Target on Ventas to $99 From $98, Maintains Outperform Rating	MT
12/08	Jefferies Adjusts Price Target on Ventas to $102 From $109, Maintains Buy Rating	MT
11/08	BMO Capital Adjusts Price Target on Ventas to $107 From $105, Keeps Outperform Rating	MT
06/08	Argus Research Adjusts Ventas Price Target to $98 From $92	MT
04/08	Citigroup Adjusts Price Target on Ventas to $110 From $100, Maintains Buy Rating	MT
04/08	Evercore ISI Adjusts Price Target on Ventas to $101 From $96, Maintains Outperform Rating	MT
03/08	BMO Capital Adjusts Price Target on Ventas to $105 From $100, Maintains Outperform Rating	MT
31/07	BNP Paribas Adjusts Ventas Price Target to $110 From $93, Maintains Outperform Rating	MT
24/07	Goldman Sachs Adjusts Price Target on Ventas to $114 From $110, Maintains Buy Rating	MT
22/07	Mizuho Adjusts Price Target on Ventas to $104 From $98, Maintains Outperform Rating	MT
16/07	Jefferies Adjusts Price Target on Ventas to $109 From $100, Maintains Buy Rating	MT
11/07	Scotiabank Adjusts Price Target on Ventas to $93 From $88	MT
01/07	Evercore ISI Adjusts Ventas Price Target to $96 From $95, Maintains Outperform Rating	MT
18/06	Scotiabank Adjusts Price Target on Ventas to $88 From $95, Maintains Sector Perform Rating	MT
16/06	Deutsche Bank Lifts Price Target on Ventas to $100 From $95, Keeps Buy Rating	MT
01/06	Wells Fargo Adjusts Price Target on Ventas to $96 From $93, Maintains Overweight Rating	MT
26/05	BofA Adjusts Price Target on Ventas to $110 From $102	MT
22/05	Baird Adjusts Price Target on Ventas to $98 From $97, Maintains Outperform Rating	MT
22/05	Mizuho Adjusts Price Target on Ventas to $98 From $94, Maintains Outperform Rating	MT
21/05	Scotiabank Adjusts Price Target on Ventas to $95 From $93, Maintains Sector Perform Rating	MT

More recommendations

Healthcare REITs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	VENTAS, INC.					+12.84%
	WELLTOWER INC.					+10.76%
	HEALTHPEAK PROPERTIES, INC.					+11.64%
	OMEGA HEALTHCARE INVESTORS, INC.					+11.88%
	AMERICAN HEALTHCARE REIT, INC.					+17.69%
	CARETRUST REIT, INC.					+15.75%
	HEALTHCARE REALTY TRUST INCORPORATED					+12.45%
	AEDIFICA					+23.31%
	SABRA HEALTH CARE REIT, INC.					+9.65%
	CHARTWELL RETIREMENT RESIDENCES					+24.06%
	Average					+15.00%
	Weighted average by Cap.					+12.18%